[Clinical aspects of Marfan syndrome]

Tina Zimmermann Belsing1, Allan Meldgaard Lund, Lars Søndergaard

  • 1Kildegårdsvej 16 B, 2. tv., Hellerup, Denmark. t.z.belsing@dadlnet.dk

Ugeskrift for Laeger
|February 1, 2011
PubMed

Insights

Marfan syndrome (MFS) is a complex inherited connective tissue disorder. A coordinated approach to diagnosis, treatment, and follow-up is crucial for improving patient outcomes and lifespan.

Area of Science:

  • Genetics and Medicine
  • Connective Tissue Diseases
  • Cardiovascular Medicine

Context:

  • Marfan syndrome (MFS) and related disorders are inherited connective tissue diseases affecting multiple organ systems.
  • Diagnosis is challenging due to overlapping symptoms with other systemic connective tissue diseases.
  • The progressive nature of the MFS phenotype necessitates careful management.

Purpose:

  • To review the diagnostic challenges and current management strategies for Marfan syndrome.
  • To highlight the importance of a coordinated approach in the diagnosis, treatment, and follow-up of MFS patients.
  • To discuss potential therapeutic advancements, including the role of angiotensin II type 1 blockers.

Summary:

  • MFS diagnosis is complex due to symptom overlap and progressive nature.
  • Improved lifespan is attributed to surgical interventions and standardized follow-up.
  • Angiotensin II type 1 blockers show potential but require further clinical trial validation.

Impact:

  • Establishes the need for integrated care strategies in Marfan syndrome management.
  • Provides a foundation for future research into MFS pathogenesis and treatment.
  • Aims to improve the quality of life and long-term prognosis for individuals with MFS.

Related Concept Videos

Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...